Diabetic Kidney Disease Market – Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Diabetic Kidney Disease Market Be Worth By 2029?
There has been consistent growth observed in the diabetic kidney disease market size over the past few years. Its growth is projected to continue, rising from $2.67 billion in 2024 to $2.8 billion in 2025, with a compound annual growth rate (CAGR) of 4.8%. Factors that have contributed to its growth during the historic period include advancements in diabetes complication awareness, improvements in diagnostic methods, the creation of ace inhibitors and arbs, the implementation of clinical trials and treatment protocols, as well as the establishment of guidelines and disease management procedures.
The market for diabetic kidney disease is projected to experience significant growth in the coming years, reaching a value of $3.53 billion in 2029 with a compound annual growth rate (CAGR) of 6.0%. This projected growth during the forecast period can be linked to several factors including the development of personalized medicine and biomarkers, an increase in global diabetes cases, concentration on altering disease therapies, implementation of telehealth and remote care, and changes in healthcare policies and reimbursement. Key trends during this period include the progress in renal replacement therapies, the inclination towards a precision medicine approach, an emphasis on early detection and diagnosis, advances in therapy, and an increase in the management of comorbidities.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9932&type=smp
What External And Internal Drivers Are Influencing The Diabetic Kidney Disease Market?
The increasing occurrence of chronic kidney disease (CKD) is anticipated to boost the diabetic kidney disease market. CKD is a long-term condition that progressively results in kidney function loss, leading to various complications like high blood pressure, anemia, and bone diseases. To treat CKD, various diagnostic and treatment options are necessary, which further drives the growth of the diabetic kidney disease market. As indicated by Kidney Research UK – a notable charity in the UK, in June 2023, around 7.2 million people, or over 10% of the UK population, were affected by CKD. Out of these, 3.25 million were in the disease’s most severe stages, while approximately 3.9 million were in the early stages—often untreated and showing no symptoms. It has been estimated that by 2033, the total number of people with chronic kidney disease in the UK could rise to 7.61 million. Thus, the increasing prevalence of chronic kidney disease is a significant factor propelling the diabetic kidney disease market’s growth in the future.
What Segmentation Insights Are Provided In The Diabetic Kidney Disease Market Research?
The diabetic kidney diseasemarket covered in this report is segmented –
1) By Type: Type 1 Diabetes; Type 2 Diabetes
2) By Treatment: Angiotensin Receptor Blockers (Arbs); Angiotensin-Converting Enzyme (Ace) Inhibitors; Antioxidant Inflammation Modulator; Calcium Channel Blockers; Other Treatments
3) By End User: Hospitals; Homecare; Specialty Centers; Other End Users
Subsegments:
1) By Type 1 Diabetes: Autoimmune-Related Diabetic Kidney Disease; Early-Onset Diabetic Kidney Disease
2) By Type 2 Diabetes: Obesity-Related Diabetic Kidney Disease; Late-Onset Diabetic Kidney Disease
Which Market Trends Are Expected To Define The Future Of The Diabetic Kidney Disease Market?
The rise of technological development is a prevalent trend noted in the diabetic kidney disease market. Maintaining their market position, various businesses involved with the diabetic kidney disease market are adopting modern technologies. For example, in August 2022, a diagnostic and healthcare devices firm from the US, Bloom Diagnostics, rolled out a new tool named the Bloom Kidney Test, which can fit seamlessly in the Bloom Smart System. This test is a medical tool that evaluates kidney health through the measurement of cystatin C levels, a trustworthy marker of kidney function. It categorizes kidney function into three levels: regular, slightly reduced, and diminished. The Bloom Smart System employs AI technology and cloud-supported algorithms to amalgamate test results with additional critical health data, like the patient’s medical background, lifestyle, and symptoms.
Who Are The Leading Companies Driving The Diabetic Kidney Disease Market?
Major companies operating in the diabetic kidney disease market include AstraZeneca plc, Pfizer Inc., Novartis AG, Bayer AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Fresenius SE & Co. KGaA, F. Hoffmann-La Roche AG, Abbott Laboratories, Reata Pharmaceuticals Inc., Merck & Co., Mitsubishi Tanabe Pharma Corporation, Johnson & Johnson pvt. Ltd., Eli Lilly and Company, GlaxoSmithKline plc, AbbVie Inc., Boehringer Ingelheim International GmbH, Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report
Which Geographic Regions Are Creating Strong Demand In The Diabetic Kidney Disease Market?
North America was the largest region in the diabetic kidney disease market in 2024. The regions covered in the diabetic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=9932&type=smp
Browse Through More Reports Similar to the Global Diabetic Kidney Disease Market 2025, By The Business Research Company
Healthcare Analytical Testing Services Global Market Report 2025
Automotive Testing Inspection And Certification Global Market Report 2025
Cold Plasma Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
